curcumin analogs (Emory/Washington University/Emory University Technology Transfer Office)

N/A

Report date: 2025/06/20 20:01:04
NME

Base Information

Drug Namecurcumin analogs (Emory/Washington University/Emory University Technology Transfer Office)
Drug Alias Namecurcumin analogs (Emory)curcumin analogs (Washington)enigmolEF-31UBS-109 +[7] 
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsVascular endothelial growth factor receptor antagonistsAngiogenesis inhibitors +[6] 
TargetsSerine/threonine-protein kinase mTORVascular endothelial growth factor receptorNuclear factor NF-kappa-B complex
Therapy Area/IndicationsDepressionInflammationNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington UniversityEmory University
Active IndicationsN/A
Inactive IndicationsDepressionInflammationNeoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A